本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Entrada Therapeutics, Inc.

9.05
-0.0800-0.88%
盘后9.050.00000.00%16:57 EDT
成交量:10.26万
成交额:92.94万
市值:3.40亿
市盈率:5.39
高:9.46
开:9.14
低:8.83
收:9.13
数据加载中...
2024/04/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/13

重要事件披露

Form 8-K - Current report
2024/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/03

重要事件披露

Form 8-K - Current report
2023/12/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities